Product information and disease descriptionPlace of product in therapyDisease description
Natural history, survival, and mortality
12 evidence topics · 13 sources
Blood pressure and vascular mortality: one million adults in 61 prospective studies
“At ages 40-69 years, each difference of 20 mm Hg usual SBP (or, approximately equivalently, 10 mm Hg usual DBP) is associated with more than a twofold difference in the stroke death rate, and with twofold differences in the death rates from IHD and from other vascular causes.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Throughout middle and old age, usual blood pressure is strongly and directly related to vascular (and overall) mortality, without any evidence of a threshold down to at least 115/75 mm Hg.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
US mortality attributed to high blood pressure
“The 2022 age-adjusted death rate attributable primarily to HBP was 31.5 per 100 000.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“From 2012 to 2022, the age-adjusted death rate attributable to HBP increased 63.2%, and the actual number of deaths attributable to HBP rose 93.0%.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“When any mention of HBP was present, the overall age-adjusted death rate in 2022 was 163.1 per 100 000.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Hypertensive emergency: in-hospital and one-year outcomes
Resistant hypertension prognosis: guideline statements
“Importantly, it has been demonstrated that patients with resistant hypertension are at a higher risk of end-organ damage and have a nearly 50% greater risk for cardiovascular events and mortality as compared to those with non-resistant disease.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Resistant hypertension prognosis: incident treated hypertension in two US health plans
“Over 3.8 years of median follow-up, cardiovascular event rates were significantly higher in those with resistant hypertension (unadjusted: 18.0% vs. 13.5%, p<0.001). After adjusting for patient and clinical characteristics, resistant hypertension was associated with a higher risk of cardiovascular events (HR 1.47, 95% CI 1.33–1.62).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Resistant hypertension prognosis: renal, cardiovascular, and mortality outcomes in 470,386 individuals
“Resistant hypertension (cRH and uRH) compared to non-RH, had multivariable adjusted hazard ratios (95% confidence intervals) of 1.32 (1.27–1.37), 1.24 (1.20–1.28), 1.46 (1.40–1.52), 1.14 (1.10–1.19), and 1.06 (1.03–1.08) for ESRD, IHE, CHF, CVA, and mortality, respectively.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The risk of ESRD and CVA and were 25% and 23% greater, respectively, in uRH compared to cRH supporting the linkage between blood pressure and both outcomes.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Resistant hypertension prognosis: ambulatory confirmation and mortality, Spanish ABPM registry
“Compared with controlled hypertension, resistant hypertension was associated with an increased risk in all-cause (HR, 1.21 [95% CI, 1.12-1.30]) and cardiovascular mortalities (HR, 1.33 [95% CI, 1.17-1.51]) in confounder-adjusted models.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“When ABPM-confirmed and white-coat resistant hypertension were separately compared with controlled hypertension, only the former was associated with an increased risk of death and cardiovascular death (HR, 1.36 [95% CI, 1.26-1.48] and 1.56 [95% CI, 1.36-1.79]), respectively.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Resistant hypertension prognosis: Thai hospital cohort
“Regarding the prognosis of aRHT, compared to non-aRHT patients, those with aRHT had significant higher risk of CAD, CKD, HF, and all-cause mortality with hazard ratios (95% CI) of 1.80 (1.56–2.08), 1.93 (1.79–2.08), 4.24 (3.54–5.08), and 2.84 (1.89–4.27), respectively.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Effect of blood pressure control within resistant hypertension
“Prospective studies using ABPM have suggested an almost 2-fold increased risk of CVD events in patients with true RH compared with those with hypertension responsive to treatment.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“BP control reduced the risk of incident stroke, coronary heart disease, or heart failure by 13% among those with RH compared with a 31% lower risk of these outcomes among patients without RH.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote